Summary
The episode highlights Proscia’s recent achievements, including being named the Global 2026 Best in KLAS for Digital Pathology in Europe and a series of product and partnership milestones such as new AI tools for skin biomarkers, virtual staining, and integration with AWS HealthImaging. It underscores the platform’s growing adoption by major labs and pharmaceutical companies, with over 12,000 pathologists using Concentriq and 16 of the top 20 pharma firms relying on it. Guest insights from Proscia’s leadership emphasize how customer‑driven feedback and robust support are driving rapid implementation and ROI in digital pathology. The discussion also touches on recent deployments at New York Gastroenterology Associates and Spaarne Gasthuis, illustrating real‑world impact on diagnostic speed and research capabilities.
Latest on TechBio News
Comments
Want to join the conversation?